Market closed

Clarivate/$CLVT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Clarivate

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Ticker

$CLVT
Sector
Industrials

Trading on

NYSE

Industry

Professional Services
Headquarters
London, United Kingdom

Employees

12,000
Website
www.clarivate.com

Clarivate Metrics

BasicAdvanced
$3.6B
-
-$1.96
1.13
-

$3.6B

1.13

$9.61

$4.25

4.2M

0.878

0.756

85.071

85.472

0.91%

1.30%

-21.14%

1.356

0.66

-0.73

9.475

-1.64%

-851.10%

13.31%

57.25%

What the Analysts think about Clarivate

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Clarivate stock.

Clarivate Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Clarivate Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Clarivate News

AllArticlesVideos
Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034

Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034

GlobeNewsWire·14 hours ago
Bargains Galore? 3 Stocks With Insider Buying in the Millions

Bargains Galore? 3 Stocks With Insider Buying in the Millions

MarketBeat·1 month ago
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover

Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CLVT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Clarivate stock?

Clarivate (CLVT) has a market cap of $3.6B as of January 15, 2025.

What is the P/E ratio for Clarivate stock?

The price to earnings (P/E) ratio for Clarivate (CLVT) stock is 0 as of January 15, 2025.

Does Clarivate stock pay dividends?

No, Clarivate (CLVT) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Clarivate dividend payment date?

Clarivate (CLVT) stock does not pay dividends to its shareholders.

What is the beta indicator for Clarivate?

Clarivate (CLVT) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.